In this episode, Winnie Sseruma and Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discuss some of the barriers to genuinely patient-centered HIV care in Africa and offer calls to action for healthcare professionals for responding to patient preferences. They discuss the efforts to improve patient-centered HIV care in the foundations and organizations for which they work. They also address issues related to stigma around HIV and complacency and lack of visibility for HIV. You will then ...
Dec 14, 2022•34 min•Ep. 229
In this episode, Iskandar Azwa, MBChB, and patient advocate Andrew Tan Tze Tho discuss barriers to genuinely patient-centered HIV care in Malaysia and the surrounding region and offer calls to action for healthcare professionals for responding to patient preferences. They discuss health literacy programs and other forms of effective health communication, especially with respect to disparate communities. They also address the prevalence of late presentation in Malaysia and the importance of getti...
Dec 07, 2022•38 min•Ep. 227
In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including: Strategies on how to approach different ARV-related toxicities Other factors to consider when assessing possible ARV-related toxicities (eg, weight gain, cardiovascular disease), such as gender-affirming care and nonmedication risk factors (eg, smoking, life stressors) Clinically relevant drug–drug interactions ...
Dec 07, 2022•18 min•Ep. 228
In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including: Novel therapeutics for HBV HCV management strategies HDV screening and linkage to care Fatty liver disease in persons with viral hepatitis Use of statins to decrease morbidity and mortality in persons with liver disease Presenter: Nancy Reau, MD Professor of Medicine Chief, Section of Hepatology Associate Director Solid Organ Transplantation Richard B. Capps Chair o...
Dec 06, 2022•8 min•Ep. 226
In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including: Hepatitis B Prevention of HBV vertical transmission when HBIg is unavailable Therapeutic vaccination for HBV cure Antiviral therapy to prevent HCC in patients with CHB in the indeterminate phase Hepatitis delta HDV prevalence in ethnically diverse, urban, safety-net populations Bulevirtide ± pegIFN-α2a for chronic HDV in the French cATU study Bulevirtide monotherapy for patients with HDV and compen...
Dec 06, 2022•41 min•Ep. 225
In this episode, Marion Elligsen, BScPhm, MSc, RPh, ACPR; Keith S Kaye, MD, MPH; and Andrew Shorr, MD, MPH, MBA, discuss key considerations for selecting empiric antibiotic regimens in patients with HABP/VABP in the intensive care unit, including: The role of novel β-lactam/β-lactamase inhibitor combinations Use of clinical predictions scores (eg, Drug Resistance in Pneumonia [DRIP] score) to predict risk for pneumonia caused by multidrug-resistant pathogens Application of rapid diagnostic testi...
Dec 06, 2022•31 min•Ep. 224
In this episode, Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS, discuss new HIV data presented at IDWeek and HIV Glasgow 2022, including Prevention strategies LA therapies Investigational agents Presenters: Chloe Orkin, MBChB, FRCP, MD Professor of HIV Queen Mary, University of London Consultant Physician Lead for HIV Research Barts Health NHS Trust The Royal London Hospital London, United Kingdom Babafemi Taiwo, MBBS Gene Stollerman Professor of Medicine Chief, Division of Infectious D...
Dec 05, 2022•38 min•Ep. 223
In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and COVID-19 rebound phenomenon, including: EPIC-HR study of nirmatrelvir plus ritonavir PINETREE study of remdesivir MOVe-OUT and Panoramic studies of molnupiravir COVID-19 rebound in treated and untreated patients Presenters: Jason Gallagher, PharmD Clinical Professor School of Pharmacy Temple University Clinical Pharmacy Specialist In...
Nov 22, 2022•47 min•Ep. 220
In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including: COVID-19 vaccines, including omicron BA.1 bivalent booster Risk factors for breakthrough COVID-19 infections COVID-19 diagnostics, including digital droplet PCR COVID-19 therapeutics, including: Nirmatrelvir plus ritonavir Tixagevimab plus cilgavimab Baricitinib Tocilizumab Inhaled interferon β-1a COVID-19 therapeutics and outcomes in patients with immunocompromise Long COVID Present...
Nov 18, 2022•37 min•Ep. 222
In this episode, Nneka Holder, MD, MPH, shares various strategies to improve meningococcal vaccine uptake in adolescent patients, including: Use of school vaccine mandates beyond entry requirements Promote more frequent visits by incorporating immunization platforms and using text or email reminders to bring patients back to the office Schedule follow-up visits before patients leave the office to increase retention Increase access and convenience by: Implementing quick, immunization-only visits ...
Nov 17, 2022•17 min•Ep. 221
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses solutions to expanding PrEP uptake. His discussion includes: Potential healthcare professional barriers to prescribing PrEP Addressing the gap in PrEP training for healthcare professionals Expanding PrEP options to facilitate adherence a...
Nov 15, 2022•11 min•Ep. 219
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, focuses on transgender women. His discussion includes: Barriers to PrEP uptake in transgender women High PrEP adherence among transgender women and transfeminine individuals in a real-world healthcare setting in New York City Presenter: Timothy J....
Nov 15, 2022•5 min•Ep. 219
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses PrEP uptake for cisgender women. His discussion includes: Prevalence of PrEP use in cisgender women in the United States Barriers to PrEP uptake in cisgender women Implementation of PrEP within family planning clinics in Atlanta PrEP in ...
Nov 15, 2022•7 min•Ep. 218
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake for people who inject drugs. His discussion includes: PrEP uptake and recommendations for people who inject drugs Project SHE: integrating PrEP with community-based syringe services for women who inject drugs Pres...
Nov 15, 2022•5 min•Ep. 219
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake in the context of racial inequities, specifically for Black and Latinx communities. His discussion includes: Inequities in PrEP uptake in Black and Hispanic and Latinx people compared with White people Structural ...
Nov 14, 2022•10 min•Ep. 217
In this episode, Paul E. Sax, MD, discusses the latest recommendations and options for HIV pre-exposure prophylaxis (PrEP), including: CDC PrEP guideline 2021 updates for oral PrEP The ANRS IPERGAY study: on-demand oral emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) PrEP in men who have sex with men who are at high risk for HIV infection A review of the HPTN 083 and 084 studies: efficacy and safety of long-acting (LA) injectable cabotegravir (CAB) vs daily oral FTC/TDF for PrEP 1-year f...
Nov 14, 2022•14 min•Ep. 214
This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US .” Hear from Thuan Vu, MD, as he discusses linkage to care after HBV diagnosis in Asian communities from a provider’s perspective. And listen to discussions with Jennifer Wild, MSN, BSN, RN, OCN, and Melinda Tran as they consider his story from a patient advocacy point of view. Topics include barriers to linkage to care like social stigma, lack of ...
Nov 14, 2022•10 min•Ep. 215
In this episode, Paul E. Sax, MD, discusses long-acting (LA) injectables for HIV treatment, including: Guidance on the use of LA cabotegravir (CAB) + rilpivirine (RPV) Risk factors for virologic failure of LA CAB + RPV The ATLAS-2M study Combined clinical trials of LA CAB + RPV Practical considerations for LA CAB + RPV Implementation of LA CAB + RPV Switching to LA CAB + RPV without an oral lead-in, including a discussion of the FLAIR extension study Supporting candidates for LA antiretroviral t...
Nov 14, 2022•20 min•Ep. 213
In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discusses strategies for and importance of HIV care engagement and reengagement for those who have fallen out of care. Her overview includes: WHO Global Health Strategy on HIV Longitudinal HIV care trajectories Promotion of successful care and antiretroviral therapy (ART) adherence Differentiated service delivery Improving care and ART adherence in high-risk groups Patient perspectives on ART persistence Presenter: Linda-G...
Nov 14, 2022•20 min•Ep. 195
This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US . ” First, Melinda Tran discusses treatment and retention of HBV care in Asian Communities in the US with Jennifer Wild, MS, BSN, RN, OCN, and Thuan Vu, MD. Their conversation offers an interesting mix of insights from the point of view of patient advocates and healthcare providers. Topics include barriers to treatment—like a lack of insurance cove...
Nov 14, 2022•12 min•Ep. 216
Patient advocate Bright Ansah shares some issues he encountered while seeking treatment after his diagnosis with HBV, including limited follow-up on lab results and a lack of compassion from his healthcare providers, and rushed health appointments. Bright’s story opens up a conversation about broader concerns about HBV treatment and retention in care with Janet Afoakwah and William Amiteye, fellow patient advocates on the panel, and Patricia D. Jones, MD, MSCR, who offers a healthcare provider’s...
Nov 14, 2022•18 min•Ep. 215
Listen as patient advocate William Amiteye uses his own experience as a Tanzanian immigrant to discuss important barriers to effective HBV screening and diagnosis, including limited knowledge about HBV from his healthcare providers, a lack of compassion toward his diagnosis from those same providers, and a limited awareness of HBV from patients in general. His story opens up an interesting and important discussion with another patient advocate on the panel, Janet Afoakwah, and Patricia D. Jones,...
Nov 14, 2022•13 min•Ep. 214
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake for adolescents. His discussion includes: How PrEP is underused in adolescents and young adults Healthcare professional barriers to provision of PrEP for adolescents A systematic review and meta-analysis of adhere...
Nov 07, 2022•8 min•Ep. 211
In this episode, Marc Thompson and Tristan J. Barber, MA, MD, FRCP, discuss some of the barriers to genuinely patient-centered HIV care in the United Kingdom and offer calls to action for healthcare professionals for responding to patient preferences. They discuss barriers to HIV testing and effectively communicating the benefits of testing to disparate communities. They also talk through the difficulties in maintaining patient engagement in HIV care and the value of using peer support workers i...
Nov 02, 2022•45 min•Ep. 209
An RSV vaccine, if approved, may reduce disease burden in older adults. In this recap of the most common questions from a symposium at the Family Medicine Experience 2022 conference, listen as we discuss when an RSV vaccine may be approved and how to overcome barriers to the implementation of vaccines for older adults in primary care settings. Hear answer to questions such as: When might potential RSV vaccines be available, and when might the Advisory Committee on Immunization Practices make rec...
Nov 02, 2022•14 min•Ep. 210
In this episode, hear Marta Boffito, MD, PhD, FRCP, and Julian Falutz, MD, FRCPC, discuss their approach to minimizing antiretroviral (ARV)-related intolerances in older patients with HIV, including: Consequences of polypharmacy Deprescribing ARV and non-ARV medications Complications associated with aging (eg, geriatric syndromes such as falls, frailty, multimorbidity) Mediations to avoid, such as anticholinergic medications, to minimize drug–drug interactions and risk of developing geriatric sy...
Nov 02, 2022•19 min•Ep. 208
In this episode, Deondre Moore and Samantha V. Hill, MD, MPH, discuss some of the barriers to genuinely patient-centered HIV care in the United States and offer calls to action for healthcare professionals for responding to patient preferences. They talk through some of the barriers that patients face, from struggling with unfamiliar medical terminology, to healthcare professional biases, to more structural problems like housing and food scarcity. They also discuss strategies that healthcare pro...
Nov 01, 2022•38 min•Ep. 207
In this episode, Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, discusses closing the HIV pre-exposure prophylaxis (PrEP) gap for Black cisgender women, including: Racial inequities in PrEP access Addressing barriers to PrEP for cisgender women such as lack of education and awareness, low perceived risk of HIV, healthcare professional bias, and medical mistrust Closing the PrEP gap through education, normalizing sexual health conversations, and decreasing stigma to empower women Samantha Strong,...
Oct 31, 2022•6 min•Ep. 206
When it comes to managing older adults with hepatitis B virus (HBV), what comorbidity, comedication, and adherence issues should be considered? Listen as Graham R. Foster, FRCP, PhD, discusses these considerations and more for strategizing the monitoring and treatment of older adults with HBV. Presenter: Graham R. Foster, FRCP, PhD Professor of Hepatology The Liver Unit Consultant Hepatologist Queen Mary University of London London, United Kingdom Link to full program: https://bit.ly/3fg9fwB Hos...
Oct 27, 2022•10 min•Ep. 205
In this episode, Latesha Elopre, MD, MSPH, discusses closing the HIV pre-exposure prophylaxis (PrEP) gap for Black men who have sex with men (MSM), including: Racial inequities in PrEP access Considering strategies to address barriers to PrEP uptake and persistence among Black MSM Considering individualized PrEP options On-demand oral emtricitabine/tenofovir disoproxil fumarate (2:1:1) Injectable cabotegravir Empowering patients to take control of their PrEP care by providing choices for optimal...
Oct 27, 2022•6 min•Ep. 203
